| 1 |
28529032 | Synergistic Cytotoxicity of Lenalidomide and Dexamethasone in Mantle Cell Lymphoma via Cereblon-dependent Targeting of the IL-6/STAT3/PI3K Axis. | 2017 Jun |
1 |
| 2 |
27657380 | The histone deacetylase inhibitor romidepsin synergizes with lenalidomide and enhances tumor cell death in T-cell lymphoma cell lines. | 2016 Oct 2 |
1 |
| 3 |
27668268 | Lenalidomide Polarizes Th1-specific Anti-tumor Immune Response and Expands XBP1 Antigen-Specific Central Memory CD3+CD8+ T cells against Various Solid Tumors. | 2015 Jun |
1 |
| 4 |
23417027 | Lenalidomide in combination with an activin A-neutralizing antibody: preclinical rationale for a novel anti-myeloma strategy. | 2013 Aug |
1 |
| 5 |
22623160 | Combination of low doses of enzastaurin and lenalidomide has synergistic activity in B-non-Hodgkin lymphoma cell lines. | 2012 Oct |
1 |
| 6 |
22640031 | Perifosine plus lenalidomide and dexamethasone in relapsed and relapsed/refractory multiple myeloma: a Phase I Multiple Myeloma Research Consortium study. | 2012 Aug |
2 |
| 7 |
21321360 | Lenalidomide targets clonogenic side population in multiple myeloma: pathophysiologic and clinical implications. | 2011 Apr 28 |
1 |
| 8 |
16494942 | Lenalidomide inhibits proliferation of Namalwa CSN.70 cells and interferes with Gab1 phosphorylation and adaptor protein complex assembly. | 2006 Jul |
1 |